Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
Authors:
Top Cited Papers
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 161, 69-81
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Zhejiang Province (LY14H270001)
- Wenzhou Municipal 551 Talented Grant
- Wenzhou Science & Technology Bureau of Grant (Y20100222)
- Wenzhou and Wenzhou Municipal Health Bureau of Grant (2010A012)
- Wenzhou Traditional Chinese Medicine Laboratory Center
- Zhejiang Province Chinese Medicine Scientific Research Fund (2013ZB121)
This publication has 10 references indexed in Scilit:
- Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-AnalysisEvidence-Based Complementary and Alternative Medicine, 2012
- Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic GluconeogenesisPLOS ONE, 2011
- Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomicsTalanta, 2010
- Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expressionMetabolism, 2010
- Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid BerberineThe Journal of Clinical Endocrinology & Metabolism, 2008
- Efficacy of berberine in patients with type 2 diabetes mellitusMetabolism, 2008
- Global burden of hypertension: analysis of worldwide dataThe Lancet, 2005
- Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statinsNature Medicine, 2004
- Worldwide prevalence of hypertensionJournal Of Hypertension, 2004
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996